Skip to main content
. 2024 Apr 3;4(4):e0003073. doi: 10.1371/journal.pgph.0003073

Table 2. SARS-CoV-2 seropositivity by participant demographics and SARS-CoV-2 exposures and risk behaviors.

Chadiza Chipata Chongwe Lusaka
SARS-CoV-2 Seropositive Adjusted Odds Ratio SARS-CoV-2 Seropositive Adjusted Odds Ratio SARS-CoV-2 Seropositive Adjusted Odds Ratio SARS-CoV-2 Seropositive Adjusted Odds Ratio
n (%) aOR 95% CI n (%) aOR 95% CI n (%) aOR 95% CI n (%) aOR 95% CI
Total 707 (43.8) 1433 (68.3) 1565 (64.1) 1591 (74.1)
Age
15–19 182 (41.6) 1 (ref) 244 (66.1) 1 (ref) 330 (63.7) 1 (ref) 154 (73.3) 1 (ref)
20–29 343 (45.1) 1.23 (0.96–1.58) 808 (67.9) 1.12 (0.86–1.46) 823 (63.3) 1.00 (0.80–1.25) 947 (73.0) 0.98 (0.69–1.40)
30–39 114 (45.4) 1.12 (0.80–1.56) 338 (70.3) 1.31 (0.96–1.79) 352 (66.3) 1.21 (0.92–1.59) 443 (76.9) 1.22 (0.83–1.80)
40–49 12 (46.2) 1.43 (0.61–3.33) 36 (83.7) 2.76 (1.16–6.58)* 60 (66.7) 1.17 (0.70–1.95) 42 (73.7) 0.98 (0.48–2.00)
Education
No education 156 (41.4) 0.91 (0.70–1.18) 108 (63.2) 0.86 (0.59–1.26) 44 (57.1) 1.17 (0.70–1.95) 16 (51.6) 0.44 (0.19–1.00)
Some primary 337 (43.3) 1 (ref) 329 (63.5) 1 (ref) 485 (60.0) 1 (ref) 296 (71.7) 1 (ref)
Completed primary 49 (36.8) 0.96 (0.64–1.43) 390 (70.5) 1.08 (0.82–1.41) 405 (66.6) 1.12 (0.89–1.42) 255 (75.7) 0.91 (0.64–1.30)
Some secondary 95 (47.5) 1.23 (0.88–1.70) 440 (71.9) 1.25 (0.96–1.63) 485 (66.3) 1.34 (1.07–1.67) 602 (74.8) 0.94 (0.70–1.25)
Completed secondary or higher 68 (55.3) 1.76 (1.17–2.64)* 161 (67.1) 1.14 (0.81–1.61) 146 (67.9) 1.64 (1.16–2.31)* 420 (75.1) 0.96 (0.71–1.31)
Occupation
Farmer 596 (43.1) 0.63 (0.37–1.10) 274 (61.9) 0.66 (0.51–0.85)* 349 (58.0) 0.70 (0.56–0.87)* 9 (90.0) 2.55 (0.30–21.85)
Daily labourer/pieceworker 4 (50.0) 1.20 (0.25–5.81) 49 (62.8) 0.76 (0.46–1.26) 205 (63.1) 0.88 (0.67–1.16) 55 (85.9) 1.93 (0.90–4.15)
Merchant/shop owner 3 (25.0) 0.25 (0.06–1.08) 30 (53.6) 0.55 (0.31–0.98)* 33 (60.0) 1.08 (0.6–1.95) 83 (76.9) 1.94 (1.19–3.18)*
Health worker 4 (50.0) 1.11 (0.24–5.10) 8 (50.0) 0.50 (0.17–1.42) 5 (83.3) 4.70 (0.48–45.97) 10 (76.9) 1.60 (0.40–6.40)
Government/civil servant 13 (48.1) 0.83 (0.32–2.19) 35 (74.5) 1.16 (0.58–2.33) 15 (88.2) 5.02 (1.07–23.47)* 61 (69.3) 0.91 (0.55–1.52)
Private sector employee 3 (50.0) 0.66 (0.11–3.95) 21 (67.7) 0.91 (0.41–2.02) 20 (80.0) 3.38 (1.19–9.58)* 107 (73.8) 1.11 (0.73–1.70)
Hawker/market seller 6 (42.9) 1.05 (0.30–3.67) 102 (71.8) 1.00 (0.67–1.51) 121 (73.8) 1.56 (1.05–2.34)* 181 (75.1) 1.20 (0.86–1.69)
Student 42 (47.2) 0.61 (0.30–1.23) 70 (73.7) 1.16 (0.70–1.91) 54 (68.4) 1.15 (0.69–1.94) 88 (79.3) 0.94 (0.56–1.58)
Unemployed 34 (54.0) 1 (ref) 719 (72.2) 1 (ref) 712 (65.4) 1 (ref) 859 (71.9) 1 (ref)
Other occupation 0 (0.0) -- -- 102 (63.0) 0.76 (0.53–1.10) 37 (68.5) 1.24 (0.66–2.33) 129 (79.6) 1.34 (0.87–2.06)
Prior COVID-19
No 678 (43.3) 1 (ref) 1389 (68.4) 1 (ref) 1525 (64.2) 1 (ref) 1518 (73.9) 1 (ref)
Yes 28 (66.7) 3.06 (1.55–6.07)* 28 (66.7) 0.95 (0.48–1.89) 22 (71.0) 1.68 (0.72–2.95) 52 (81.2) 1.25 (0.64–2.45)
Household COVID-19
No 684 (43.5) 1 (ref) 1379 (68.5) 1 (ref) 1451 (63.8) 1 (ref) 1458 (73.5) 1 (ref)
Yes 17 (47.2) 1.20 (0.60–2.38) 31 (63.3) 0.95 (0.51–1.77) 36 (75.0) 1.45 (0.71–2.95) 112 (81.8) 1.19 (0.75–1.91)
Close COVID-19 contact
No 629 (43.7) 1 (ref) 1348 (69.0) 1 (ref) 1277 (64.1) 1 (ref) 1365 (73.3) 1 (ref)
Yes 11 (36.7) 0.93 (0.42–2.05) 32 (61.5) 0.80 (0.44–1.46) 41 (66.1) 0.95 (0.53–1.67) 140 (79.5) 1.10 (0.73–1.66)
COVID-19 vaccination
No 396 (36.4) 1 (ref) 1057 (64.7) 1 (ref) 1164 (60.5) 1 (ref) 1379 (72.4) 1 (ref)
Yes 299 (58.5) 1.76 (1.40–2.21)* 363 (80.3) 1.48 (1.13–1.93)* 381 (78.4) 1.40 (1.09–1.80)* 208 (88.1) 1.97 (1.29–3.02)*
HIV status
Negative 767 (44.0) 1 (ref) 1212 (67.5) 1 (ref) 1404 (65.4) 1 (ref) 1388 (75.3) 1 (ref)
Positive 16 (33.3) 0.83 (0.43–1.59) 203 (72.8) 1.42 (1.05–1.90)* 113 (52.6) 0.77 (0.57–1.05) 104 (63.4) 0.87 (0.60–1.26)

aOR = adjusted odds ratio (adjusted for enrollment month); CI = confidence interval.

Close contact defined as being within 2 meters of someone outside the household suspected or confirmed to have COVID-19 for greater than 15 minutes

≥1 dose of any COVID-19 vaccine.

*p-value<0.05